Adastra Labs Holdings Ltd. (XTRX) AI Stock Analysis

21 Followers

Adastra Labs Holdings Ltd.

(CNQX:XTRX)

Select Model

Rating:45Neutral

Price Target:CAD 0.21▲(2.50% Upside)

Action:reiterated

Date:12/18/25

The overall stock score is primarily impacted by the company's poor financial performance, which is the most significant factor. Technical analysis provides some moderate support, but the negative valuation metrics further weigh down the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Positive Factors

Specialized B2B extraction and formulationAdastra Labs operates a focused, specialty business supplying refined cannabinoid ingredients to manufacturers. That B2B ingredient model is durable: it relies on production know-how and contract relationships rather than retail foot traffic, supporting steady demand from downstream brands and potential for long-term supply agreements.

Negative Factors

Declining revenue and large lossesRevenues are declining materially while net margins are deeply negative, indicating the business is shrinking while losing cash on sales. Sustained top-line contraction combined with heavy losses undermines scale economics, limits reinvestment capacity, and makes achieving a durable turnaround more difficult without clear demand or margin recovery.

Adastra Labs Holdings Ltd. (XTRX) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 1.12M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.7
Beta (1Y): 0.60
Revenue Growth: ―
EPS Growth: ―
Country: Canada
Employees: 21
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Adastra Labs Holdings Ltd. Business Overview & Revenue Model

Company Description

Adastra Holdings Ltd. is a company specializing in solutions for cannabis processing and extraction. It provides a variety of services, including comprehensive analytical testing and processing for cannabis. The company offers its processing expertis...

How the Company Makes Money

null

Adastra Labs Holdings Ltd. Financial Statement Overview

Summary

The company faces significant financial challenges, with declining revenues and substantial losses. The balance sheet reflects financial instability with negative equity, and cash flow issues further exacerbate the situation, indicating a need for strategic financial restructuring.

Income Statement

30Negative

Balance Sheet

20Very Negative

Cash Flow

25Negative

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Dec 2020
Income Statement
Total Revenue	16.86M	24.84M	22.22M	13.30M	5.63M	2.50M
Gross Profit	5.44M	8.31M	7.57M	6.11M	1.94M	785.58K
EBITDA	-13.15M	-11.21M	-1.41M	-2.62M	-1.39M	-7.07M
Net Income	-14.49M	-13.24M	-3.54M	-4.28M	-2.75M	-8.07M
Balance Sheet
Total Assets	16.01M	19.34M	32.34M	31.80M	28.76M	13.74M
Cash, Cash Equivalents and Short-Term Investments	786.60K	1.30M	1.38M	1.01M	744.54K	1.15M
Total Debt	3.57M	3.62M	3.64M	3.95M	3.59M	2.50M
Total Liabilities	16.96M	17.89M	17.66M	13.57M	6.38M	3.65M
Stockholders Equity	-947.25K	1.45M	14.69M	18.23M	22.37M	10.09M
Cash Flow
Free Cash Flow	-101.81K	410.06K	1.18M	694.07K	-1.64M	-4.63M
Operating Cash Flow	-315.28K	826.23K	1.86M	1.32M	-1.05M	-2.83M
Investing Cash Flow	-714.54K	-416.18K	-681.05K	-1.03M	-262.81K	-1.79M
Financing Cash Flow	-213.55K	-492.29K	-815.12K	-22.55K	915.98K	3.40M

Adastra Labs Holdings Ltd. Technical Analysis

Technical Analysis SentimentNegative

Last Price0.20

Price Trends

50DMA0.20Positive

100DMA0.20Positive

200DMA0.20Negative

Market Momentum

MACD-0.00Negative

RSI13.97Positive

STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:XTRX, the sentiment is Negative. The current price of 0.20 is below the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.20, and below the 200-day MA of 0.20, indicating a neutral trend. The MACD of -0.00 indicates Negative momentum. The RSI at 13.97 is Positive, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:XTRX.

Adastra Labs Holdings Ltd. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:XTRX against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:LABS	53Neutral	CAD 25.63M	-5.60	-13.79%	―	-6.74%	43.54%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:XTRX	45Neutral	CAD 1.12M	-0.67	272.01%	―	―	―
TSE:AVCN	44Neutral	CAD 13.44M	-2.62	-108.44%	―	-0.23%	-142.54%
TSE:OILS	43Neutral	CAD 3.40M	-1.75	-43.92%	―	-18.30%	-397.37%
TSE:PCLO	42Neutral	CAD 9.34M	-2.67	28.59%	―	0.90%	57.73%

* Healthcare Sector Average

Performance Comparison

TSE:XTRX and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:XTRX	Adastra Labs Holdings Ltd.	0.20	-0.01	-4.76%
TSE:LABS	Medipharm Labs (Otc)	0.07	-0.01	-7.14%
TSE:PCLO	Pharmacielo	0.05	0.01	11.11%
TSE:OILS	Nextleaf Solutions	0.02	-0.04	-63.64%
TSE:AVCN	Avicanna Inc	0.09	-0.17	-66.67%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Dec 18, 2025

Adastra Labs Holdings Ltd. AI Stock Analysis